Latest From Alexander Wallroth
2022 Global Biopharma R&D Productivity And Growth Ranking
Bookmark
-
Analysis
The R&D productivity of the top 30 largest biopharma companies decreased slightly from 2021 to 2022 and the sector saw the lowest number of FDA approvals in the past 10 years.
Advertisement
Harry McQuillan
Email Author
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.